BriaCell Therapeutics Corp. (TSE:BCT – Get Free Report) shares shot up 2.9% during mid-day trading on Tuesday . The stock traded as high as C$5.27 and last traded at C$5.24. 3,387 shares were traded during mid-day trading, a decline of 83% from the average session volume of 19,511 shares. The stock had previously closed at C$5.09.
BriaCell Therapeutics Stock Performance
The firm has a market capitalization of C$45.41 million, a price-to-earnings ratio of -6.21 and a beta of 1.98. The business has a fifty day moving average price of C$4.67 and a 200 day moving average price of C$5.64.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and improve patients’ lives. Immunotherapies have become the forefront of the fight against cancer because they use the body’s immune system to destroy cancer cells, offer the potential for higher levels of safety and efficacy than chemotherapy, and may also prevent cancer recurrence.
Read More
- Five stocks we like better than BriaCell Therapeutics
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
